Alkermes plc. Restructuring Reserve, Foreign Currency Translation Gain (Loss)
Alkermes plc. (ALKS) reported Restructuring Reserve, Foreign Currency Translation Gain (Loss) of $100.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-10-29.
Discontinued › Notes
us-gaap:RestructuringReserveTranslationAdjustment · last filed 2015-10-29
- Alkermes plc. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2015-09-30 was $0.00.
- Alkermes plc. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2015-06-30 was $0.00.
- Alkermes plc. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2015-03-31 was $100.00K, a 80.00% decline year-over-year.
- Alkermes plc. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2014-09-30 was -$400.00K.
| Period end | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 3 month | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 6 month | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 9 month | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 9 month as first filed | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 derived: sum of 2 quarters · filed 2015-10-29 | $100.00K 10-Q · filed 2015-10-29 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $100.00K 10-Q · filed 2015-07-30 | |||
| 2015-03-31 | $100.00K 10-Q · filed 2015-04-30 | ||||
| 2014-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$400.00K derived: sum of 2 quarters · filed 2014-10-29 | $100.00K 10-Q · filed 2014-10-29 | -$100.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $500.00K 10-Q · filed 2014-07-31 | $300.00K derived: sum of 3 quarters · filed 2015-02-24 | ||
| 2014-03-31 | $500.00K 10-Q · filed 2014-04-30 | $300.00K derived: sum of 2 quarters · filed 2015-02-24 | |||
| 2013-12-31 | -$200.00K derived: 10-K 9 month − 10-Q 6 month · filed 2015-02-24 | $100.00K 10-K · filed 2015-02-24 | $600.00K 10-KT · filed 2014-02-27 | ||
| 2013-09-30 | $300.00K 10-Q · filed 2013-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |